|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Share-based compensation | |||
| Depreciation, amortization and impairment | |||
| Increase in accrued interest on short-term and long-term deposits | |||
| Operating lease right-of-use assets and liabilities, net | |||
| Finance (income) expenses | |||
| Amortization of premium and accretion of discount on marketable securities, net | |||
| Decrease (increase) in trade receivables, net | |||
| Decrease (increase) in prepaid expenses and other assets | |||
| Increase (decrease) in trade payables | |||
| Increase (decrease) in employees and payroll accruals | |||
| Increase in accrued expenses and other liabilities | |||
| Increase in deferred revenues | |||
| Increase (decrease) in deferred taxes, net | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from investing activities: | |||
| Purchase of intangible assets | |||
| Capitalization of software development costs | |||
| Purchase of property and equipment | |||
| Investment in short-term deposits | |||
| Proceeds from short-term deposits | |||
| Investment in restricted deposits | |||
| Proceeds from restricted deposits | |||
| Investment in marketable securities | |||
| Proceeds from maturity of marketable securities | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from initial public offering, net of underwriting discounts and commissions and other issuance costs | |||
| Proceeds from exercise of options | |||
| Proceeds from employees share purchase plan | |||
| Investment from redeemable non-controlling interest | |||
| Issuance of preferred shares, net of issuance costs | |||
| Net cash provided by financing activities | |||
| Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash | |||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash - beginning of year | |||
| Cash, cash equivalents and restricted cash - end of year | |||
| Supplemental disclosures of cash flow information: | |||
| Cash paid for income taxes, net of refunds | |||
| Supplemental disclosures of noncash investing and financing activities: | |||
| Lease liabilities arising from obtaining right-of-use-assets | |||
| Purchase of property and equipment, accrued but not paid | |||
| Issuance of ordinary shares in connection with asset acquisition | |||
| Conversion of convertible preferred shares | |||
| Reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above: | |||
| Cash and cash equivalents | |||
| Restricted cash – included in short-term and long-term restricted deposits. |
Loading...
